TSE:4151Pharmaceuticals
Kyowa Kirin (TSE:4151) Stock Falls As Profit Strength Meets Growth Doubts
Kyowa Kirin walked into this earnings release with its stock under pressure, down roughly 8% over both the past week and month, even as trailing earnings looked strong. The headline today is simple. Profitability stayed solid, yet the market is still treating the stock as if the story is fragile.
The key tension is between emotion and margins. Net profit margin over the past year sat in the mid-teens and earnings quality was described as high, but investors appear more focused on slower...